SHCM
ALXN

Sachem Head Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Sachem Head Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-635,000
Closed -$77M – 17
2017
Q1 		$77M Sell
635,000
-300,000
-32% -$36.4M 2.49% 14
2016
Q4 		$114M Buy
+935,000
New +$114M 4.38% 11